A Strategic Blueprint to Cure Canada’s Innovation Paralysis in Life Sciences

How Canada Can Keep the Companies, Capital and Returns Its Research Creates

Canada funds world-class life sciences research, but too often the companies it creates, and the returns they generate, end up owned and grown elsewhere. This independent blueprint follows a company from the lab to the anchor stage and sets out 61 reforms, led by an eight-reform priority package that needs no new discovery funding.

Version 1.0 · October 26, 2026 · Natalie Yeadon · DOI: 10.5281/zenodo.23621505